These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11708909)

  • 1. Monosaccharide-linked inhibitors of O(6)-methylguanine-DNA methyltransferase (MGMT): synthesis, molecular modeling, and structure-activity relationships.
    Reinhard J; Hull WE; von der Lieth CW; Eichhorn U; Kliem HC; Kaina B; Wiessler M
    J Med Chem; 2001 Nov; 44(24):4050-61. PubMed ID: 11708909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of 131I-labeled glucose-conjugated inhibitors of O6-methylguanine-DNA methyltransferase (MGMT) and comparison with nonconjugated inhibitors as potential tools for in vivo MGMT imaging.
    Mühlhausen U; Schirrmacher R; Piel M; Lecher B; Briegert M; Piee-Staffa A; Kaina B; Rösch F
    J Med Chem; 2006 Jan; 49(1):263-72. PubMed ID: 16392811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of O(6)-methylguanine-DNA methyltransferase by glucose-conjugated inhibitors.
    Reinhard J; Eichhorn U; Wiessler M; Kaina B
    Int J Cancer; 2001 Aug; 93(3):373-9. PubMed ID: 11433402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of O6-methylguanine-DNA methyltransferase by glucose-conjugated inhibitors: comparison with nonconjugated inhibitors and effect on fotemustine and temozolomide-induced cell death.
    Kaina B; Mühlhausen U; Piee-Staffa A; Christmann M; Garcia Boy R; Rösch F; Schirrmacher R
    J Pharmacol Exp Ther; 2004 Nov; 311(2):585-93. PubMed ID: 15254145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acridine-O
    Franco Pinto J; Fillion A; Duchambon P; Bombard S; Granzhan A
    Eur J Med Chem; 2022 Jan; 227():113909. PubMed ID: 34731767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single cycle of treatment with temozolomide, alone or combined with O(6)-benzylguanine, induces strong chemoresistance in melanoma cell clones in vitro: role of O(6)-methylguanine-DNA methyltransferase and the mismatch repair system.
    Alvino E; Castiglia D; Caporali S; Pepponi R; Caporaso P; Lacal PM; Marra G; Fischer F; Zambruno G; Bonmassar E; Jiricny J; D'Atri S
    Int J Oncol; 2006 Oct; 29(4):785-97. PubMed ID: 16964376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The synthesis and properties of tricyclic analogues of S6-methylthioguanine and O6-methylguanine.
    Hornillo-Araujo AR; Burrell AJ; Aiertza MK; Shibata T; Hammond DM; Edmont D; Adams H; Margison GP; Williams DM
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):1099-102. PubMed ID: 18058544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged inhibition of O(6)-methylguanine DNA methyltransferase in human tumor cells by O(6)-benzylguanine in vitro and in vivo.
    Kreklau EL; Kurpad C; Williams DA; Erickson LC
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1269-75. PubMed ID: 10565851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of single- versus double-bolus treatments of O(6)-benzylguanine for depletion of O(6)-methylguanine DNA methyltransferase (MGMT) activity in vivo: development of a novel fluorometric oligonucleotide assay for measurement of MGMT activity.
    Kreklau EL; Liu N; Li Z; Cornetta K; Erickson LC
    J Pharmacol Exp Ther; 2001 May; 297(2):524-30. PubMed ID: 11303039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance-modifying agents. 8. Inhibition of O(6)-alkylguanine-DNA alkyltransferase by O(6)-alkenyl-, O(6)-cycloalkenyl-, and O(6)-(2-oxoalkyl)guanines and potentiation of temozolomide cytotoxicity in vitro by O(6)-(1-cyclopentenylmethyl)guanine.
    Griffin RJ; Arris CE; Bleasdale C; Boyle FT; Calvert AH; Curtin NJ; Dalby C; Kanugula S; Lembicz NK; Newell DR; Pegg AE; Golding BT
    J Med Chem; 2000 Nov; 43(22):4071-83. PubMed ID: 11063604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitization of pancreatic tumor xenografts to carmustine and temozolomide by inactivation of their O6-Methylguanine-DNA methyltransferase with O6-benzylguanine or O6-benzyl-2'-deoxyguanosine.
    Kokkinakis DM; Ahmed MM; Chendil D; Moschel RC; Pegg AE
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3801-7. PubMed ID: 14506174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational Study of Novel Natural Inhibitors Targeting O
    Yang L; Li W; Zhao Y; Zhong S; Wang X; Jiang S; Cheng Y; Xu H; Zhao G
    World Neurosurg; 2019 Oct; 130():e294-e306. PubMed ID: 31203065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The specific role of O
    Sun G; Zhao L; Zhong R; Peng Y
    Future Med Chem; 2018 Aug; 10(16):1971-1996. PubMed ID: 30001630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug Efflux Pumps Attenuate the Effect of MGMT Inhibitors.
    Tomaszowski KH; Schirrmacher R; Kaina B
    Mol Pharm; 2015 Nov; 12(11):3924-34. PubMed ID: 26379107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential inactivation of O6-methylguanine-DNA methyltransferase activity by O6-arylmethylguanines.
    Mineura K; Fukuchi M; Kowada M; Terashima I; Kohda K
    Int J Cancer; 1995 Sep; 63(1):148-51. PubMed ID: 7558444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-selective O6-alkylguanine-DNA alkyltransferase inhibitors: design, synthesis, and evaluation of 6-(benzyloxy)-2-(aryldiazenyl)-9H-purines as prodrugs of O6-benzylguanine.
    Zhu R; Baumann RP; Penketh PG; Shyam K; Sartorelli AC
    J Med Chem; 2013 Feb; 56(3):1355-9. PubMed ID: 23311288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of O(6)-methylguanine-DNA methyltransferase increases azoxymethane-induced colonic tumors in rats.
    Wali RK; Skarosi S; Hart J; Zhang Y; Dolan ME; Moschel RC; Nguyen L; Mustafi R; Brasitus TA; Bissonnette M
    Carcinogenesis; 1999 Dec; 20(12):2355-60. PubMed ID: 10590233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retroviral-mediated expression of the P140A, but not P140A/G156A, mutant form of O6-methylguanine DNA methyltransferase protects hematopoietic cells against O6-benzylguanine sensitization to chloroethylnitrosourea treatment.
    Maze R; Kurpad C; Pegg AE; Erickson LC; Williams DA
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1467-74. PubMed ID: 10454526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depletion of O6-methylguanine-DNA methyltransferase by O6-benzylguanine enhances 5-FU cytotoxicity in colon and oral cancer cell lines.
    Murakami J; Lee YJ; Kokeguchi S; Tsujigiwa H; Asaumi J; Nagatsuka H; Fukui K; Kuroda M; Tanaka N; Matsubara N
    Oncol Rep; 2007 Jun; 17(6):1461-7. PubMed ID: 17487405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on potentiation of nitrosourea-cytotoxicity by DNA repair enzyme inhibitors in human brain tumor cells].
    Fukuchi M; Mineura K; Kowada M; Terashima I; Kohda K
    No To Shinkei; 1997 Jun; 49(6):521-8. PubMed ID: 9198092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.